NADPH Oxidase: A Potential Target for Treatment of Stroke

Abstract EN

Stroke is the third leading cause of death in industrialized nations.

Oxidative stress is involved in the pathogenesis of stroke, and excessive generation of reactive oxygen species (ROS) by mitochondria is thought to be the main cause of oxidative stress.

NADPH oxidase (NOX) enzymes have recently been identified and studied as important producers of ROS in brain tissues after stroke.

Several reports have shown that knockout or deletion of NOX exerts a neuroprotective effect in three major experimental stroke models.

Recent studies also confirmed that NOX inhibitors ameliorate brain injury and improve neurological outcome after stroke.

However, the physiological and pathophysiological roles of NOX enzymes in the central nervous system (CNS) are not known well.

In this review, we provide a comprehensive summary of our current understanding about expression and physiological function of NOX enzymes in the CNS and its pathophysiological roles in the three major types of stroke: ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.